Antengene Corporation Limited (SEHK: 6996) announced it will present preclinical data on ATG-207, an experimental autoimmune disease treatment, at the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE